Biopharma Bucking Market Trends on Positive FDA Feedback
31 Octubre 2024 - 11:00AM
AllPennyStocks.com
This firm’s treatment for a disfiguring skin infection has
demonstrated safety and efficacy across multiple Phase 2 and Phase
3 studies, and shares are holding their own despite
today's...
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Appili Therapeutics (TSX:APLI)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024